AMRN has been the subject of several other research reports. StockNews.com started coverage on Amarin in a research note on Thursday, October 5th. They set a hold rating for the company. Jefferies Financial Group cut Amarin from a buy rating to a hold rating and decreased their price target for the company from $3.00 to $1.00 in a research note on Wednesday, October 25th.
Amarin Stock Down 3.5 %
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of AMRN. Quantbot Technologies LP acquired a new position in shares of Amarin during the first quarter worth approximately $31,000. Resources Management Corp CT ADV increased its position in shares of Amarin by 759.9% during the first quarter. Resources Management Corp CT ADV now owns 10,319 shares of the biopharmaceutical company’s stock worth $855,000 after acquiring an additional 9,119 shares in the last quarter. Arete Wealth Advisors LLC acquired a new stake in shares of Amarin in the 1st quarter worth about $16,575,000,000. Creative Planning lifted its position in Amarin by 66.4% in the 2nd quarter. Creative Planning now owns 17,285 shares of the biopharmaceutical company’s stock valued at $26,000 after acquiring an additional 6,900 shares in the last quarter. Finally, 1834 Investment Advisors Co. bought a new position in Amarin in the 1st quarter valued at about $29,000. Institutional investors and hedge funds own 25.51% of the company’s stock.
Amarin Company Profile
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
- Five stocks we like better than Amarin
- What is the NASDAQ Stock Exchange?
- The most upgraded stocks in November have two things in common
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Monday.com rocked earnings like it’s the weekend
- What is Forex and How Does it Work?
- Plan to own one retailer? Make it this one
Receive News & Ratings for Amarin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarin and related companies with MarketBeat.com's FREE daily email newsletter.